Attached files
| file | filename |
|---|---|
| EX-31.3 - EX-31.3 - CYTOKINETICS INC | cytk-ex313_6.htm |
| EX-31.2 - EX-31.2 - CYTOKINETICS INC | cytk-ex312_11.htm |
| EX-31.1 - EX-31.1 - CYTOKINETICS INC | cytk-ex311_7.htm |
| EX-10.5 - EX-10.5 - CYTOKINETICS INC | cytk-ex105_87.htm |
| EX-10.4 - EX-10.4 - CYTOKINETICS INC | cytk-ex104_126.htm |
| EX-10.3 - EX-10.3 - CYTOKINETICS INC | cytk-ex103_169.htm |
| EX-10.2 - EX-10.2 - CYTOKINETICS INC | cytk-ex102_170.htm |
| EX-10.1 - EX-10.1 - CYTOKINETICS INC | cytk-ex101_171.htm |
| 10-Q - 10-Q - CYTOKINETICS INC | cytk-10q_20200930.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER
Pursuant to 18. U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that the Quarterly Report of Cytokinetics, Incorporated on Form 10-Q for the quarterly period ended September 30, 2020 fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m) and the that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Cytokinetics, Incorporated.
Dated: November 6, 2020
|
|
/s/ Robert I. Blum |
|
|
Robert I. Blum |
|
|
President and Chief Executive Officer (Principal Executive Officer) |
|
|
|
|
|
/s/ Ching Jaw |
|
|
Ching Jaw |
|
|
Senior Vice President, Chief Financial Officer (Principal Financial Officer) |
|
|
|
|
|
/s/ Robert Wong |
|
|
Robert Wong |
|
|
Vice President, Chief Accounting Officer (Principal Accounting Officer) |